Reimagining the Future of Scientific Writing, CAPTIS Copilot leverages cutting-edge AI models for the Medical Device and Diagnostic Industry
Chicago, IL – August 2, 2023. Celegence, a regulatory compliance service and software solution company, today announced the launch of CAPTIS Copilot, the most advanced document automation and literature review solution for the life sciences industry. CAPTIS Copilot is an enterprise cloud-based platform leveraging pre-trained large language models (LLM) and Reinforcement Learning from Human Feedback (RLHF) for the device and diagnostic industry. This cloud-based solution significantly advances the ability of device and IVD manufacturers to increase innovation and empower clinical, regulatory, and medical writing teams to be more strategic and productive with their time.
CAPTIS Copilot reenergizes medical writers, enhancing productivity, quality, and consistency in the creation of MDR and IVDR compliant documentation. With CAPTIS Copilot, Celegence’s own medical writing team has drastically improved the consistency and reliability of post market surveillance documentation such as scientific literature summaries, clinical evaluations, safety reports and summary of safety and performance documents. Celegence built this cloud-based software specifically for MDR and IVDR compliance, with a focus on PMS documentation including report creation and automated scientific literature reviews. A combination of both AI and traditional automation have cut the time it takes to write PMS documentation in half, allowing manufacturers to invest more time and money into delivering safe and effective products to patients.